Latest / Decera Clinical Education Oncology Podcast
Future Treatment Strategies for Acute Myeloid Leukemia—Emerging Targeted Therapy Combinations and Beyond
In this episode, Naval G. Daver, MD, discusses promising investigational agents and treatment combinations in clinical trials for patients with newly diagnosed and relapsed/refractory AML, including:
FLT3 inhibitors crenolanib and quizartinib
Anti-CD47 antibody magrolimab
IMGN632, a CD123 antibody–drug conjugate
Anti-CD70 antibody cusatuzumab
APR-246, targeting the TP53 mutation
Content is part of an online CME program supported by an educational grant from Daiichi-Sankyo.
Link to full program, including a ClinicalThought commentary: https://bit.ly/2Y2uCG2
Hosted by Simplecast, an AdsWizz…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.